Safety and Efficacy of Genolimzumab (GB226) in Combination With Fruquintinib in the Treatment of Relapsed or Metastatic NSCLC With EGFR-sensitive Mutation

2019 ◽  
Author(s):  
Keyword(s):  
Safety And Efficacy ◽  
Metastatic Nsclc

Brigatinib in the first-line treatment of ALK+ metastatic NSCLC: safety and efficacy

2021 ◽  
Author(s):  
Giuseppe Bronte ◽  
Alessandro Cafaro ◽  
Luigi Pasini ◽  
Ilaria Priano ◽  
Kalliopi Andrikou ◽  
...  
Keyword(s):  
Line Treatment ◽  
First Line ◽  
Safety And Efficacy ◽  
Metastatic Nsclc ◽  
First Line Treatment

scholarly journals Entrectinib for the treatment of metastatic NSCLC: safety and efficacy

2020 ◽  
Vol 20 (5) ◽  
pp. 333-341 ◽  
Author(s):  
Andrea Sartore-Bianchi ◽  
Elio Gregory Pizzutilo ◽  
Giovanna Marrapese ◽  
Federica Tosi ◽  
Giulio Cerea ◽  
...  
Keyword(s):  
Safety And Efficacy ◽  
Metastatic Nsclc

805: Safety and Efficacy of Gentamycin Bladder Irrigations in Complex Urologic Patients

2005 ◽  
Vol 173 (4S) ◽  
pp. 218-218
Author(s):  
William DeFoor ◽  
Denise Ferguson ◽  
Susan Mashni ◽  
Deborah Reeves ◽  
Lisa Creelman ◽  
...  
Keyword(s):  
Safety And Efficacy

Abstract #1233: 9-Month Safety and Efficacy of Saroglitazar in Diabetic Dyslipidemia

2015 ◽  
Vol 21 ◽  
pp. 291-292
Author(s):  
Shashank Joshi ◽  
Jothydev Kesavadev ◽  
Sudhir Bhandari ◽  
Banshi Saboo ◽  
Ashok Jaiswal ◽  
...  
Keyword(s):  
Diabetic Dyslipidemia ◽  
Safety And Efficacy
Sign in / Sign up

Export Citation Format

Share Document